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Abstract 
 
Background 
Research prioritisation can help identify clinically relevant questions and encourage high-
quality, patient-centred research. Delphi methodology aims to develop consensus opinion 
within a group of experts, with recent Delphi projects helping to define the research agenda 
and funding within several medical and surgical specialties. 
 
Methods 
All members of the Association of Upper Gastrointestinal Surgeons (AUGIS) were asked to 
submit clinical research questions using an online survey; Phase 1). Two consecutive rounds 
of Delphi prioritisation by multidisciplinary HPB healthcare professionals (Phase 2) were 
undertaken to establish a final list of the most highly prioritised research questions. A 
multidisciplinary steering committee analysed the results of each phase. 
 
Results 
Ninety-three HPB-focussed questions were identified in Phase 1, with thirty-seven questions 
of sufficient priority to enter a further prioritisation round. A final group of 11 questions 
considered highest priority were identified. The most highly ranked research questions 
related to treatment pathways, operative strategies and the impact of HPB procedures on 
quality of life, particularly for malignant disease.  
 
Discussion 
Expert consensus has identified research priorities within the UK HPB surgical community 
over the coming years. Funding applications, to establish well-designed, high quality 
collaborative research are now required to address these questions. 
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Introduction 
Methodological and practical difficulties present unique challenges to the surgical research 
community1, with research quality historically variable and often poor1,2. Integration of 
research and practice through a collaborative approach can often overcome such challenges3 
and enhance research impact, such as the Dutch Pancreatic Cancer Group in hepato-
pancreato-biliary (HPB) surgery4-6. 
 
Identifying a national consensus on research priorities provides the opportunity to increase 
value and reduce waste in HPB research7. Furthermore, the engagement of stakeholders in 
research encourages the development of clinically relevant research priorities and the 
potential for national collaboration in HPB research. Using structured prioritisation methods 
to achieve consensus can maximise relevance, guide funding bodies and channel resources. 
 
 
The modified Delphi methodology can be utilised to produce consensus within a group of 
experts by interaction to reduce individual bias. These methods have previously identified 
research questions in orthopaedic8 and colorectal surgery9, with outputs frequently receiving 
pump-priming or significant funding following identification10-12. However, to the authors 
knowledge, clinical priority setting in HPB surgery is yet to be performed. 
 
The aim of this work is to identify a list of highly prioritised clinical research questions in 
HPB surgery using a modified Delphi approach to guide future research and funding bodies. 
  
Methods 
A modified Delphi approach was performed with two distinct phases, including two rounds 
of prioritisation (Figure 1) using methodology previously described across a broad range of 
medical topics9,13,14. Throughout the process, stakeholders were encouraged to consider 
prioritisation responses based on disease burden, clinical relevance and answerability - 
factors identified as facilitators of high-impact research15. During each round, any incomplete 
questionnaires were excluded prior to analysis. 
 
Phase one 
Healthcare professionals within the AUGIS membership were asked to submit potential 
research questions across upper gastrointestinal and HPB surgery via an online survey. This 
was open to both medical professionals and multidisciplinary team members, with no limit on 
the number of research questions an individual could submit. The survey was open for at 
least six weeks, with at least one reminder email was sent during this period and through 
social media platforms to increase engagement with the process.  
 
All submitted questions were then grouped into four categories independently (hepato-
pancreato-biliary, malignant upper gastrointestinal surgery, benign upper gastrointestinal 
surgery or bariatric surgery), with any disagreements resolved by consensus. HPB-focussed 
questions were then screened, with duplicate questions removed and similar questions 
streamlined following discussion by the steering group. Where questions related to an 
identical clinical research problem, questions were combined by group consensus. Where 
wording of questions was altered, agreement was reached within the steering group and care 
was taken not to alter the meaning of original questions posed. 
 
Due to the separate sub-speciality interest within clinical practice, questions relating to the 
other three categories (malignant upper gastrointestinal surgery, benign upper gastrointestinal 
surgery and bariatric surgery) were each taken forward by individually selected and 
speciality-orientated steering groups. 
 
Steering committee 
The steering committee for the Delphi process contained two surgical registrars (SK, SP), a 
cancer nurse specialist (LJ), patient and public representation (HD), a medical oncologist 
with specialist interest in HPB disease (AC) and three consultant HPB surgeons (JR, EMH, 
MT). Representation from within the Association of Upper Gastrointestinal Surgeons 
(AUGIS) committee (Education, Training and Research Lead; MT) was also present.  
 
Phase two 
The collated list of research questions was then prioritised by attendees at the Great Britain 
and Ireland Hepato-Pancreato-Biliary Association (GBIHPBA) conference, March 2018, 
using printed questionnaires (Prioritisation Round 1). Healthcare professionals with a 
speciality interest in HPB surgery were asked to prioritise each individual research question 
based on their own opinion using a Likert scale (1 – low priority, 3 – neutral, 5 – high 
priority), in accordance with similar Delphi processes8,9,13,14. 
 
Scores were reviewed with a ‘cut-off’ point determined based on mean priority score and 
steering group consensus to select those questions to move through to the final round. 
Heterogeneity of responses was also examined by the steering committee to ensure ‘block’ 
voting was not performed. To ensure higher-level evidence did not already exist, a literature 
search of each remaining question was conducted prior to inclusion. 
 A second round of prioritisation was then performed by the GBIHPBA membership via a 
further online survey, with healthcare professionals asked to prioritise each question using the 
same Likert scale as the previous round. Again, respondents were given a minimum of six 
weeks with reminders sent through email and social media during this period. Results were 
reviewed by the steering committee to identify a final group of highly prioritised questions, 
with consensus reached by analysing the mean priority score and proportion of high priority 
responses each question received. 
 
  
  
Results 
A total of 427 research questions were produced by 140 respondents, representing 48% of the 
membership (Figure 2). Sub-specialisation in HPB surgery was declared by 47 (34%). 
Overall 153 (36%) research questions were HPB-focused. A summary of question topic in 
each round of the prioritisation exercise is shown in Table 1.  
 
After duplicated and similar questions had been combined, 93 questions were moved forward 
into round 2. These research questions were prioritised by 44 respondents, representing 44% 
of the conference attendees, with a further four responses excluded due to incompleteness. 
Assessment of ranking heterogeneity excluded one further response due the possible presence 
of ‘block’ ranking (only priority ranks of 1 or 5 present). Following steering committee 
review, a consensus was reached regarding a cut-off value (mean priority score of ≥3.0) and a 
total of 37 questions were brought forward into the last round (Supplementary Table 1). 
 
In the final round 42 respondents prioritised these 37 questions, with three excluded due to 
incompleteness. Following steering committee review of responses, a consensus was again 
reached regarding cut-off value (questions receiving >50% high priority ranking (grade 4 or 
5) in combination with a mean priority score of ≥3.5; and <20% low priority ranking (1 or 2); 
Supplementary Table 2) to produce 11 final highly prioritised questions (Box 1). Across the 
three rounds consultant representation remained above 50% and group demographic 
remained similar (Figure 3). 
 
  
Discussion 
A list of 11 high priority research topics in HPB surgery have been derived through a 
modified Delphi process.  
 
A high proportion of these topics related to malignant disease, particularly regarding 
improving outcomes in pancreatic cancer and the operative management of colorectal cancer 
liver metastases. This is expected, particularly as they represent a high burden of disease16,17, 
significant reduction in patient’s quality of life and potential for improvement in survival 
outcomes16,18. Furthermore there is considerable debate regarding these diseases if one 
considers the potential roles of neoadjuvant therapy or pathways to surgery among patients 
with pancreatic cancer and of two stage liver resection (Associating Liver Partition and Portal 
vein Ligation for Staged hepatectomy (ALPPS) in particular). In the case of pancreatic 
cancer, early stage disease detection and the development of new treatment strategies have 
previously been identified as priorities eight years ago19. Progress within these domains has 
since been made, however they may remain high priorities due to difficulties in translating 
basic research to bedside20 and persistent complexities within surgical research21. 
 
A national quality improvement programme for iatrogenic common bile duct injury was 
sufficiently prioritised for consideration in the final group of questions (Supplementary Table 
2), however nearly a quarter of respondents (24%) ranked this question as low priority (grade 
1 or 2). Due to priority rank heterogeneity and unanimous concern within the steering 
committee regarding difficulties in feasibility of delivering change at a national level, this 
question was not included within the final list. Thus, this Delphi process highlights areas 
where further review or data is required before those areas are the focus of 
study/improvement. All final round questions have been published here for transparency and 
to acknowledge that a proportion of questions are linked by topic or clinical management 
algorithms. In addition, differences in patient prioritisation may exist and as academic 
advances are achieved they may develop higher priority in the coming years. The authors also 
acknowledge that current ongoing studies, of which current progress and results are 
unknown, may answer some of the high-ranked questions. It is hoped this process will 
support any conclusions regarding the clinical significance of their findings. 
 
Greater representation of benign and/or complex biliary disease may have been anticipated, 
particularly as it represents a significant disease burden and associated clinical workload22. 
Biliary sub-speciality interest was well represented across each round (data not shown) and 
therefore this is unlikely to explain their absence in the final set of topics for suggested 
review. It is possible that questions relating to biliary disease will be prioritised in the upper 
gastrointestinal surgery Delphi exercise run in parallel to this study, or that bias exists within 
the UK system towards cancer-based questions due to the focus on development of cancer 
care centres.  
 
Throughout the prioritisation process, clinicians have been integral to identifying critical 
priorities in the surgical management of HPB disease, avoiding potential mismatches 
between those questions clinicians wish to be addressed in research and those questions that 
researchers choose to investigate7,23,24. 
 
The use of a large cohort of healthcare professionals through the AUGIS and GBIHPBA 
membership has reduced reporter bias and set priorities using a large multi-disciplinary 
cohort containing healthcare professionals representing both clinical and academic foci. 
While a variety of methods have been described to determine consensus, there is no 
agreement as to the best approach25. Therefore the ‘certain level of agreement’ method was 
adopted as this is the most commonly used methodology in consensus-based methodology. 
 
Low member response rates could be highlighted as a limitation to this study, particularly as 
responses were received from less than half the membership in each round (47.6, 33.6 and 
32% respectively). However, similar studies using Delphi methodology have demonstrated 
lower response rates, with many quoting around 10 to 18%9,14. This suggests adequate 
engagement in the process and represents the largest collation of expert opinion on HPB 
research priorities to date.  
 
The use of paper questionnaires could have introduced the potential for respondents to readily 
identify questions of particular interest in block voting during phase 2, particularly as 
questions were presented in identical order. However the assessment of rank heterogeneity 
identified only one response where this may have occurred, suggesting the introduction of 
bias remained limited. 
 
This study also highlights the process of developing a national consensus statement for HPB 
research priorities. The final priority list may differ from other geographical and cultural 
settings, however this process could be utilised by other national and international groups to 
perform further Delphi prioritisation exercises specific to unanswered research questions 
prominent within their surgical community. 
 
Within the steering group a patient representative reviewed questions during phase two to 
ensure patient relevance and interpretation of question structure. However, exploration of 
patient perceptions and validation of the final question group with a larger cohort is required 
to ensure patient-centred research is achieved7,25. The development of clinical vignettes 
through patient and public involvement may also help further guide funding bodies, similar to 
the work performed by McNair et al following the similar process performed for colorectal 
surgery26. 
 
The questions will be disseminated to funding bodies and encourage championing of 
individual research questions by AUGIS members. Meanwhile, the newly appointed AUGIS 
pancreatic cancer research lead, a joint initiative with Pancreatic Cancer UK and Pancreatic 
Cancer Research Fund, will provide a platform on which such questions can be answered. It 
is anticipated the output from the current study will set the research agenda in HPB surgery 
and hope it will further encourage contribution to planned research and collaboration between 
centres over the coming years.  
 
In summary this Delphi process has set high research priorities in HPB surgery, which it is 
hoped will align research agendas and principle users. Malignant disease was highly 
prioritised, relating to treatment pathways and specific operative strategies, together with the 
impact of HPB procedures on quality of life. 
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Tables 
 
Table 1. Question topics included in each round 
 
 
Topic Submitted in Phase 1 Collated questions in 
Round 2 voting 
Highest scores for 
Round 3 voting 
Final list of prioritisation 
research questions 
Total 153* 93 37 11 
Cancer 49 31 17 5 
Benign 21 13 3 - 
Surgical technique 19 13 3 1 
Complications 13 8 1 - 
Prehabilitation 9 5 2 1 
Screening  8 4 2 1 
Liver transplant 3 3 2 - 
Perioperative 5 3 1 - 
Chronic pancreatitis 4 2 2 1 
Palliative care 4 2 - 1 
Education 1 1 - - 
Miscellaneous 17 8 4 1 
*Overall 427 questions were produced in phase 1, of which 153 were hepato-pancreato-biliary (HPB) focused 
  
Box 1. Final group of prioritised research questions in HPB surgery* 
Pancreas 
1.  How do you identify patients with resectable pancreatic cancer who would benefit from neoadjuvant 
chemotherapy and/or radiotherapy? Is there a role for surgical resection in patients with pancreatic cancer 
down staged by neoadjuvant chemotherapy and/or radiotherapy? In those patients with locally advanced 
disease, in whom should resection be offered? 
 
2.  Which blood and urine markers can identify early stage pancreatic cancer? 
 
3.  Does fast track surgery for pancreatic carcinoma improve overall outcome in terms of reduced morbidity and 
improved survival? Which patient cohort is suitable for fast-track surgery and in whom should biliary 
drainage be performed pre-operatively? 
 
4.  What is the natural history of intraductal papillary mucinous neoplasms? How should patients with detected 
lesions be managed? 
 
5.  In patients at high risk of pancreatic cancer, either hereditary or chronic pancreatitis, what is the optimal 
radiological surveillance (modality and frequency)? 
 
 
Liver 
6.  In patients with colorectal cancer and synchronous liver metastases, which patients benefit from combined 
primary site surgery and metastasectomy? 
 
7.  Is there a role for genetic or molecular prognostic/predictive markers in selecting patients for resection of 
colorectal liver metastases? What is the role of biological agents in colorectal liver metastases and what 
prognostic markers improve outcomes? 
 
8.  For patients with bilobar colorectal liver metastases in whom a single stage resection is not feasible, which 
technique is superior with regard to oncological outcomes and patient-reported outcomes - ALPPS or 
conventional 2-stage hepatectomy with portal venous embolization? 
 
 
Cross-speciality 
9.  Does a prehabilitation programme, including the optimisation of nutrition, improve outcomes of HPB 
surgery? 
 
10.  What is the impact of the cancer nurse specialist on HPB patients, their clinical and patient-reported 
outcomes, and their carers? 
 
11.  How do we maximise quality of life and survival for patients with unresectable HPB cancer? What is the 
role of nutrition in this patient group? 
 
 
*Note that these questions have been listed under topic headings and do not represent rank order  
Figure legends 
 
Figure 1. The modified Delphi process used to prioritise research questions in hepato-
pancreato-biliary surgery 
 
Figure 2. Overview of responses during modified Delphi process 
 
Figure 3. Distribution of responder demographics through three rounds of prioritisation by 
clinical grade 
